Dr. Agarwal'S Eye Hospital Ltd (BSE: 526783) is a Chennai, Tamil Nadu-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹2,434 Cr, it ranks #1,115 by market cap among the 6,189 Indian listed companies on FinBizNet, and #4 of 18 in Medical Diagnostic Centres. At ₹5,035.80 (as of 26 Oct 2026), the share price is 8.4% below its 52-week high of ₹5,500.00 and 2.8% above its 52-week low of ₹4,899.50. The share price is up 20.0% over one year and up 5.2% over three months.
| Current Price | ₹5,035.80 |
|---|---|
| Market Cap | ₹2,434 Cr |
| BSE Code | 526783 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 34.3 |
| Return on Equity | 25.22% |
| Return on Assets | 9.03% |
| 52-Week Range | ₹4,899.50 – ₹5,500.00 |
| 1-Year Price Change | +20.0% |
| 3-Month Price Change | +5.2% |
| Beta (1Y) | 0.11 |
| Dividend Yield | 0.16% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.dragarwal.com |
Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
1. Healthcare Facilities & Services-This segment operates hospital and health related services, nursing homes, clinics, medical, other research institutions, and other health care facilities for eye care and treatment. It is also involved in the trading of optical frames and lens, pharmaceutical products, contact lens and related accessories, and food items. 2. Medical Services-This segment provides eye care services. It also operates pediatric and squint clinics. 3. Trading Activities-This segment sells healthcare equipments. 4. Corporate-0
1. Eye Care Related Sales and Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,311 Cr | 82.8 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹10,849 Cr | 56.9 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,357 Cr | 45.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,434 Cr | 34.3 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,617 Cr | 16.1 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,559 Cr | 48.4 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹670 Cr | 23.5 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹535 Cr | 20.3 | — | ₹81 Cr | — |
| Star Imaging And Path Lab Limi | ₹130 Cr | 6.7 | — | — | -43.0% |
Listed by market capitalisation. Ratios are shown for context only.
Dr. Agarwal'S Eye Hospital Ltd is trading at ₹5,035.80, with a market capitalisation of ₹2,434 Cr.
Dr. Agarwal'S Eye Hospital Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Dr. Agarwal'S Eye Hospital Ltd has a P/E of 34.3 and a return on equity of 25.22%.
Dr. Agarwal'S Eye Hospital Ltd is listed on the BSE under the scrip code 526783.
Dr. Agarwal'S Eye Hospital Ltd's share price is up 20.0% over one year and up 5.2% over three months. Its 52-week range is ₹4,899.50 to ₹5,500.00.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.